-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Tg Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2015 to Q4 2024.
- Tg Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending December 31, 2024 was $11.9M, a 26.6% increase year-over-year.
- Tg Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending December 31, 2024 was $42.5M, a 12.1% increase year-over-year.
- Tg Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $42.5M, a 12.1% increase from 2023.
- Tg Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $37.9M, a 15% decline from 2022.
- Tg Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $44.6M, a 27.2% decline from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)